Arbutus Biopharma (ABUS) Non-Current Assets (2010 - 2026)
Arbutus Biopharma (ABUS) reported Non-Current Assets of $142,000 for Q2 2026, down 4.1% from $148,000 a year earlier and down 7.2% from the prior quarter.
Powered by 
Analysis
Arbutus Biopharma (ABUS) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Arbutus Biopharma posted Non-Current Assets of $162,000, down 96.3% from FY2024.
- Non-Current Assets has declined for three consecutive years, with a five-year compound annual growth rate of -55.6% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $4.39 million in FY2024 (-64.5%), $12.37 million in FY2023 (-72.1%), $44.28 million in FY2022 (+1.0%) and $43.82 million in FY2021 (+367.4%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q4 2010.
- Year over year, Non-Current Assets has now declined in each of the last 14 quarters, with an average decline of 67.2% over the last eight quarters.
- The high point for year-over-year Non-Current Assets in five years was Q1 2022 (growth of 621.2%); the low point was Q2 2025 (a decline of 98.7%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $153,000 (Q1 2026), $162,000 (Q4 2025) and $268,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Arbutus Biopharma | 960.50 Mn | 587.48 Mn | - | 142,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 142,000.00 |
| Mar 31, 2026 | 153,000.00 |
| Dec 31, 2025 | 162,000.00 |
| Sep 30, 2025 | 268,000.00 |
| Jun 30, 2025 | 148,000.00 |
| Mar 31, 2025 | 202,000.00 |
| Dec 31, 2024 | 4.39 Mn |
| Sep 30, 2024 | 7.66 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 14.42 Mn |
| Dec 31, 2023 | 12.37 Mn |
| Sep 30, 2023 | 17.03 Mn |
| Jun 30, 2023 | 18.02 Mn |
| Mar 31, 2023 | 38.37 Mn |
| Dec 31, 2022 | 44.28 Mn |
| Sep 30, 2022 | 62.67 Mn |
| Jun 30, 2022 | 58.05 Mn |
| Mar 31, 2022 | 64.18 Mn |
| Dec 31, 2021 | 43.82 Mn |
| Sep 30, 2021 | 39.06 Mn |
API Access
Arbutus Biopharma Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABUS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "ABUS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=ABUS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();